Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Nihonbashi Life Science HUB

Jan 15, 2024 10:00 AM - Jan 16, 2024 6:00 PM

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

8th DIA Cell and Gene Therapy Products Symposium in Japan


8th DIA Cell and Gene Therapy Products Symposium in Japan

 “Development of Cell and Gene Therapy Products in the New Growth Phase”


Click Here to View the Japanese Program


Click Here to View the English Program


Who should attend?

  •  Individuals involved in the development of regenerative medical products in pharmaceutical or medical device companies and related industries.
  • Individuals involved in the development of regenera - tive medical products in venture companies or academic institutions.
  • Individuals involved in regulatory submissions work for regenerative medical products.

Program Committee

  • Kiyoshi  Okada, MD, PhD
    Kiyoshi Okada, MD, PhD Vice Director, Medical Ctr for Translational Research,Dept of Medical Innovation
    Osaka University Hospital, Japan
  • Hiromi  Okabe, PhD
    Hiromi Okabe, PhD Immunology, Regulatory Affairs Japan,Global Drug Development Division
    Novartis Pharma K.K, Japan
  • Yasuko  Terao, PhD
    Yasuko Terao, PhD Head, External Scientific Engagement, R&D Japan Region,
    Takeda Pharmaceutical Co., Ltd., Japan
  • Teruyo  Arato, PhD
    Teruyo Arato, PhD Professor, Clinical Research and Medical Innovation Center
    Hokkaido University Hospital, Japan
  • Satoru  Hayata, MS
    Satoru Hayata, MS
    Sobi Japan, Japan
  • Ryutaro  Hirasawa
    Ryutaro Hirasawa CMC Regulatory Affairs, Manager
    Daiichi Sankyo Co., Ltd., Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh Associate Director, Regulatory Development Dept.
    Janssen Pharmaceutical K.K., Japan
  • Ikuo  Kawauchi
    Ikuo Kawauchi Senior Expert,International Standards Promotion Office,Intellectual Property Div
    FUJIFILM Holdings Corporation, Japan
  • Sumimasa  Nagai, MD, PhD
    Sumimasa Nagai, MD, PhD Institute for Advancement of Clinical and Translational Science(iACT)
    Kyoto University Hospital, Japan
  • Shinichi  Noda
    Shinichi Noda Deputy Review Director, Office of Cellular and Tissue-based Products
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Hiroyuki  Suda, MSc
    Hiroyuki Suda, MSc VP, Clinical Development Strategy
    KORTUC Inc., Japan
  • Yoshie  Tsurumaki
    Yoshie Tsurumaki Group Manager, Cell & Gene Franchise
    Novartis Pharma K.K., Japan
  • Keiji  Miyamoto
    Keiji Miyamoto Principal Post-Marketing Regulatory Affairs Dep.
    Daiichi Sankyo Co.,Ltd., Japan
  • Akiko  Nishioka
    Akiko Nishioka Clinical Research Associate, Clinical Operation
    Novartis Pharma K.K., Japan
  • Yoji  Sato, PhD
    Yoji Sato, PhD Head, Division of Drugs
    National Institute of Health Sciences, Japan
  • Masafumi  Onodera, MD, PhD
    Masafumi Onodera, MD, PhD Director, Center of Gene Cell Therapy Promotion,
    National Center for Child Health and Development, Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.